[1] |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer, 2015, 136(5): E359-386.
|
[2] |
Yu P, Huang L, Cheng G, et al. Treatment strategy and prognostic factors for Krukenberg tumors of gastric origin: report of a 10-year single-center experience from China [J]. Oncotarget, 2017, 8(47): 82558-82570.
|
[3] |
曹阳,刘志苏. Krukenberg瘤的治疗及预后探讨 [J]. 临床外科杂志, 2012, 20(4): 288-289.
|
[4] |
杨广建,杨林. 胃癌卵巢转移Krukenberg瘤的研究进展 [J]. 癌症进展, 2017, 15(5): 494-497.
|
[5] |
Yamanishi Y, Koshiyama M, Ohnaka M, et al. Pathways of metastases from primary organs to the ovaries [J]. Obstet Gynecol Int, 2011, 2011: 612817.
|
[6] |
Kakushima N, Kamoshida T, Hirai S, et al. Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor [J]. J Gastroenterol, 2003, 38(12):1176-1180.
|
[7] |
Yook JH, Oh ST, Kim BS. Clinical prognostic factors for ovarian metastasis in women with gastric cancer [J]. Hepatogastroenterology, 2007, 54(75): 955-959.
|
[8] |
Cho JH, Lim JY, Choi AR, et al. Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with krukenberg tumor [J]. Cancer Res Treat, 2015, 47(4): 697-705.
|
[9] |
Yoshida M, Sugino T, Kusafuka K, et al. Peritoneal dissemination in early gastric cancer: importance of the lymphatic route [J]. Virchows Arch, 2016,469(2): 155-161.
|
[10] |
Lobo J, Machado B, Vieira R, et al. The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor [J]. Virchows Arch, 2017, 470(1): 69-80.
|
[11] |
马振敕,张汝鹏,薛强, 等. 110例胃癌卵巢转移瘤的预后因素分析 [J]. 中华胃肠外科杂志, 2016, 19(3): 287-291.
|
[12] |
Bruls J, Simons M, Overbeek LI, et al. A national population-based study provides insight in the origin of malignancies metastatic to the ovary [J]. Virchows Arch, 2015, 467(1): 79-86.
|
[13] |
管建云,白东晓,李守淼. 以转移性卵巢癌为首发表现的胃癌25例临床分析 [J]. 肿瘤基础与临床, 2014, 30(3): 60-62.
|
[14] |
Kiyokawa T, Young RH, Scully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations [J]. Am J Surg Pathol, 2006, 30(3): 277-299.
|
[15] |
李海明,强金伟,赵书会, 等. 源自胃癌的转移性卵巢肿瘤的MRI研究 [J]. 中国医学计算机成像杂志, 2014, 20(6): 517-521.
|
[16] |
Willmott F, Allouni KA, Rockall A. Radiological manifestations of metastasis to the ovary [J]. J Clin Pathol, 2012, 65(7): 585-590.
|
[17] |
Antila R, Jalkanen J, Heikinheimo O. Comparison of secondary and primary ovarian malignancies reveals differences in their pre-and perio-perative characteristics [J]. Gynecol Oncol, 2006, 101(1): 97-101.
|
[18] |
Kikkawa F, Shibata K, Ino K, et al. Preoperative findings in non- gynecologic carcinomas metastasizing to the ovaries [J]. Gynecol Obstet Invest, 2002, 54(4): 221-227.
|
[19] |
Al-Agha OM, Nicastri AD. An in-depth look at Krukenberg tumor: an overview [J]. Arch Pathol Lab Med, 2006, 130(11): 1725-1730.
|
[20] |
Kubecek O, Laco J, Spacek J, et al. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review [J]. Clin Exp Metastasis, 2017, 34(5): 295-307.
|
[21] |
Kim KH, Lee KW, Baek SK, et al. Survival benefit of gastrectomy+/- metastasectomy in patients with metastatic gastric cancer receiving chemotherapy [J]. Gastric Cancer, 2011, 14(2): 130-138.
|
[22] |
Gadde R, Tamariz L, Hanna M, et al. Metastatic gastric cancer (MGC) patients: Can we improve survival by metastasectomy? A systematic review and meta-analysis [J]. J Surg Oncol, 2015, 112(1): 38-45.
|
[23] |
Lu LC, Shao YY, Hsu CH, et al. Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer [J]. Anticancer research, 2012, 32(8): 3397-3401.
|
[24] |
Brieau B, Auzolle C, Pozet A, et al. Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study [J]. Dig Liver Dis, 2016, 48(4): 441-445.
|
[25] |
Kim WY, Kim TJ, Kim SE, et al. The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries [J]. Eur J Obstet Gynecol Reprod Biol, 2010, 149(1): 97-101.
|
[26] |
Rosa F, Marrelli D, Morgagni P, et al. Krukenberg tumors of gastric origin: the rationale of surgical resection and perioperative treatments in a multicenter western experience [J]. World J Surg, 2016, 40(4): 921-928.
|
[27] |
Jiang R, Tang J, Cheng X, et al. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors [J]. Eur J Surg Oncol, 2009, 35(1): 92-97.
|
[28] |
Chang YR, Han DS, Kong SH, et al. The value of palliative gastrectomy in gastric cancer with distant metastasis [J]. Ann Surg Oncol, 2012, 19(4): 1231-1239.
|
[29] |
Kim NK, Kim HK, Park BJ, et al. Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma [J]. Cancer, 1999, 85(7): 1490-1499.
|
[30] |
Lynne T Shuster, Bobbie S Gostout, Brandon R Grossardt, et al. Prophylactic oophorectomy in pre-menopausal women and long term health–a review [J]. Menopause Int, 2008, 14(3): 111-116.
|
[31] |
朱瑞,于雁. 动脉介入化疗栓塞在胃癌伴卵巢转移库肯勃氏瘤治疗中的应用 [J]. 中国处方药, 2016, 14(3): 107.
|
[32] |
Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial [J]. Lancet, 2010, 376(9742): 687-697.
|